1:05pm ET
Health and Healthcare
How the FDA Is Fighting the Nationwide EpiPen Shortage
The FDA is extending the expiration dates for certain EpiPens in light of the national shortage ahead of the back-to-school season.
Companies
Mylan Inc.
MYL Coverage
Page 31:55pm ET
Health and Healthcare
Are Teva and Mylan Entering an EpiPen Price War to Zero?
Mylan has had a stranglehold on the market for EpiPen, but this is all changing after the FDA approved Teva for a generic version of it.
8:45am ET
Investing
Top Analyst Upgrades and Downgrades: Akamai, Dollar Tree, Hasbro, Intel, Mylan, Netflix, Papa John’s and More
The top analyst upgrades, downgrades and other research calls from Monday included Akamai, Dollar Tree, Hasbro, Intel, Mylan, Netflix and Papa John's.
11:55am ET
Investing
6 Stocks Defying the Bull Market With Multiple Analyst Downgrades and Price Target Cuts
24/7 Wall St. tracked six companies that saw three or more analyst downgrades or price target cuts on Thursday, August 9, 2018.
9:10am ET
Investing
Top Analyst Upgrades and Downgrades: Applied Materials, Extreme Networks, Mylan, NXP, Roku, Seagate, Yelp, Zynga and More
The top analyst upgrades, downgrades and other research calls from Thursday include Applied Materials, Extreme Networks, Mylan, NXP, Roku, Seagate, Yelp and Zynga.
11:35am ET
Health and Healthcare
Why Mylan Is Paying the Price for Q2
Mylan reported disappointing quarterly results before the markets opened on Wednesday, and shares retreated afterward.
Chris Lange 10:25am ET
Investing
Disney, Snap, Roku and More Earnings Coming This Week
24/7 Wall St. has put together a preview of Disney, Snap, CVS Health and some of the other companies that are about to report their quarterly results.
9:10am ET
Health and Healthcare
Adamis and Novartis Team Up Against Mylan
Adamis Pharmaceuticals saw its shares shoot up early on Monday after the firm announced a partnership with a subsidiary of Novartis.
4:08pm ET
Investing
Thursday’s Biggest Winners and Losers in the S&P 500
Thursday was a positive day for the broad U.S. markets. Again, the Nasdaq hit an all-time high in the session reaching closer to 7,800. The S&P 500 is still holding just below…
8:40am ET
Health and Healthcare
Mylan Wins Big With FDA Approval
Mylan saw its shares make a handy gain early on Tuesday after the FDA announced a key approval for Fulphila (pegfilgrastim-jmbd), a biosimilar to Neulasta (pegfilgrastim).
Chris Lange 10:15am ET
Investing
Disney, Groupon, Nvidia and More Major Earnings Coming This Week
24/7 Wall St. has put together a preview of Disney, Nvidia, Valeant Pharmaceuticals and of some of the other top companies reporting their latest results in the coming week.
9:00am ET
Investing
Top Analyst Upgrades and Downgrades: Albermarle, American Airlines, Ellie Mae, Johnson & Johnson, Mallinckrodt, Mylan, NetApp, Southwest Air and More
The top analyst upgrades, downgrades and other research calls from Thursday include Albermarle, American Airlines, Ellie Mae, Johnson & Johnson, Mallinckrodt, Mylan, NetApp and Southwest Airlines.
8:55am ET
Investing
Top Analyst Upgrades and Downgrades: AON, Broadcom, Expedia, Exxon, Match, Mylan, Ocean Rig UDW, Signet, Transocean and More
The top analyst upgrades, downgrades and other research calls from Thursday include AON, Broadcom, Expedia, Exxon Mobil, Match, Mylan, Ocean Rig UDW, Signet Jewelers and Transocean.
11:30am ET
Health and Healthcare
Is It Finally Time to Buy Into Mylan?
Mylan has been through the ringer over the past couple of years, but by the looks of it, this stock could be turning around.
Chris Lange 9:00am ET
Investing
Top Analyst Upgrades and Downgrades: ADM, Cardlytics, Dermira, E*Trade, Herbalife, Mylan, UPS, VMware, Western Digital and More
The top analyst upgrades, downgrades and other research calls from Tuesday include Archer Daniels Midland, Cardlytics, Dermira, E*Trade, Herbalife, Mylan, UPS, VMware and Western Digital.